Komori

Notice of Release of Video Presentation on Third-Quarter Financial Results for the Fiscal Year Ending December 2026

Results presentationNine months, FY ending Dec 2026Published 2026-11-17 16:00

The video presentation on the financial results for the third quarter of the fiscal year ending December 2026 was released on 17 November 2026. The video explains the business overview, business strategy and future growth strategy.

In short

Forecast raised
  • Released a financial results presentation video for the third quarter of the fiscal year ending December 2026.
  • The video explains the business overview, business strategy and future growth strategy.
  • The video became available on 17 November 2026.

What decks usually leave out

COMPUTED = worked out by Komori from reported numbers; the rest are stated in this deck

Financial targets

the last five years against the target (green band), where one is stated
Computed
Return on equity-141.6%
profit earned on shareholders' money
−85.2 pts on last year
-144%-87%-30%FY24/12FY25/12FY26/12FY24/12: -31.6%FY25/12: -56.4%FY26/12: -141.6% (forecast)-141.6%
Return on equity
Period%
FY24/12-31.6
FY25/12-56.4
FY26/12-141.6
Equity ratio18.8%
how much of the balance sheet is owned outright
−24.3 pts on last year
17%58%98%FY23/12FY24/12FY25/12FY26/12FY23/12: 93.7%FY24/12: 96.0%FY25/12: 43.1%FY26/12: 18.8%18.8%
Equity ratio
Period%
FY23/1293.7
FY24/1296.0
FY25/1243.1
FY26/1218.8

Yearly figures are computed by Komori from J-Quants results data (ROE = net profit ÷ average equity). The last point is this year's forecast or latest figure. Targets show only when this deck states them.

Not mentioned in this deck

18
Company KPIsBy businessWhat movedNew initiativesCapital spendingShare buybackDividendSelf-rating against planForecast assumptionsRisks priced into the forecastMid-term plan targetsA stated financial targetOrders and backlogPrice and volumeStore or site countHeadcountMarket size and shareInvestor Q&A
Notice of Release of Video Presentation on Third-Quarter Financial Results for the Fiscal Year Ending December 2026 | K Pharma,Inc. (4896) timely disclosure | Komori